GRI Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapies for inflammatory, fibrotic, and autoimmune diseases. It focuses on its lead program, GRI-0621, an inhibitor of type 1 invariant Natural Killer T (iNKT) cell activity and is being developed as a novel oral therapeutic for the treatment of idiopathic pulmonary fibrosis. The company was founded by Vipin Kumar Chaturvedi in May 2009 and is headquartered in La Jolla, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
4
Frequently Asked Questions
What is Market Cap of GRI Bio Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. GRI Bio Inc market cap is $3.92M.
What is the 52-week high for GRI Bio Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. GRI Bio Inc 52 week high is $30.43 as of September 10, 2025.
What is the 52-week low for GRI Bio Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. GRI Bio Inc 52 week low is $1.10 as of September 10, 2025.
What is GRI Bio Inc stock price today?
GRI Bio Inc stock price today is $1.57.
What was GRI Bio Inc stock price yesterday?
GRI Bio Inc stock price yesterday was $1.56.
What is the PE ratio of GRI Bio Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. GRI Bio Inc’s P/E ratio is -0.06.
What is the Price-to-Book ratio of GRI Bio Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. GRI Bio Inc P/B ratio is 1.1725.
What is the 50-day moving average of GRI Bio Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. GRI Bio Inc 50-day moving average is $1.56.